{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:17:23Z","timestamp":1795029443257,"version":"4.10.2"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Tumor Treating Fields (TTFields) therapy is an approved cancer treatment modality, based on non-invasive application of electric fields to the tumor region. Proteomic and cell biology methods revealed a versatile mechanism of action to be involved in the response to TTFields. In the current research we performed whole transcriptome analysis across tumor types to identify pan-cancer responses to TTFields. For this we collected samples from control and TTFields-treated human cancer cell lines of gastric cancer, pancreatic cancer, ovarian cancer, non-small cell lung carcinoma, pleural mesothelioma, and glioblastoma. The transcriptomic analysis supported previous reported effects: downregulation of pathways associated with cell cycle, cell growth, and proliferation; downregulation of DNA replication and the FA-BRCA DNA repair pathway; and upregulation of cellular responses to stress\u2014senescence, autophagy, and apoptosis. Notably, previously unrecognized downstream effects of TTFields were revealed on cellular metabolism, with downregulation of protein and RNA metabolism, and upregulation of steroid biosynthesis. Additional DNA repair pathways were also found to be downregulated, including nucleotide excision repair, base excision repair, and mismatch repair. In conclusion, this study revealed similar response patterns to TTFields across different tumor types, re-enforcing some already pinpointed mechanisms, while revealing new mechanisms. Unlocking these new mechanisms may allow identification of potential new cancer treatments for application together with TTFields based on mechanistical compatibility.<\/jats:p>","DOI":"10.1038\/s41420-025-02615-5","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:55:20Z","timestamp":1752137720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The transcriptomic fingerprint of cancer response to Tumor Treating Fields (TTFields)"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5634-8978","authenticated-orcid":false,"given":"Kerem","family":"Wainer-Katsir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Haber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hila","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianghao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Story","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renfei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6021-1841","authenticated-orcid":false,"given":"Ulf D.","family":"Kahlert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mannarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Mirimao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9835-7870","authenticated-orcid":false,"given":"Monica","family":"Lupi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8784-1360","authenticated-orcid":false,"given":"Maurizio","family":"D\u2019Incalci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitit","family":"Lavy-Shahaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hila","family":"Ene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni","family":"Frechtel-Gerzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeina","family":"Drawshy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Martinez-Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Dor-On","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaara","family":"Porat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1489-4175","authenticated-orcid":false,"given":"Moshe","family":"Giladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Palti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"2615_CR1","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1158\/0008-5472.CAN-22-0887","volume":"82","author":"JC Moser","year":"2022","unstructured":"Moser JC, Salvador E, Deniz K, Swanson K, Tuszynski J, Carlson KW, et al. The mechanisms of action of tumor treating fields. Cancer Res. 2022;82:3650\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-0887.","journal-title":"Cancer Res"},{"key":"2615_CR2","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1080\/09553002.2020.1837984","volume":"97","author":"NK Karanam","year":"2021","unstructured":"Karanam NK, Story MD. An overview of potential novel mechanisms of action underlying Tumor Treating Fields-induced cancer cell death and their clinical implications. Int J Radiat Biol. 2021;97:1044\u201354. https:\/\/doi.org\/10.1080\/09553002.2020.1837984.","journal-title":"Int J Radiat Biol"},{"key":"2615_CR3","doi-asserted-by":"publisher","first-page":"TPS4199","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS4199","volume":"41","author":"HM Babiker","year":"2023","unstructured":"Babiker HM, Macarulla T, Philip PA, Becerra CR, Dragovich T, Picozzi VJ. Phase 3 PANOVA-3 study: Tumor treating fields (TTFields) therapy concomitant with gemcitabine and nab-paclitaxel (GnP) for front-line treatment of locally advanced pancreatic cancer. J Clin Oncol. 2023;41:TPS4199. https:\/\/doi.org\/10.1200\/JCO.2023.41.16_suppl.TPS4199.","journal-title":"J Clin Oncol"},{"key":"2615_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.trsl.2019.10.003","volume":"217","author":"NK Karanam","year":"2020","unstructured":"Karanam NK, Ding L, Aroumougame A, Story MD. Tumor treating fields cause replication stress and interfere with DNA replication fork maintenance: implications for cancer therapy. Transl Res. 2020;217:33\u201346. https:\/\/doi.org\/10.1016\/j.trsl.2019.10.003.","journal-title":"Transl Res"},{"key":"2615_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1158\/1078-0432.CCR-17-1117","volume":"24","author":"EJ Mun","year":"2018","unstructured":"Mun EJ, Babiker HM, Weinberg U, Kirson ED, Von Hoff DD. Tumor-treating fields: a fourth modality in cancer treatment. Clin Cancer Res. 2018;24:266\u201375. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1117.","journal-title":"Clin Cancer Res"},{"key":"2615_CR6","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1158\/0008-5472.can-04-0083","volume":"64","author":"ED Kirson","year":"2004","unstructured":"Kirson ED, Gurvich Z, Schneiderman R, Dekel E, Itzhaki A, Wasserman Y, et al. Disruption of cancer cell replication by alternating electric fields. Cancer Res. 2004;64:3288\u201395. https:\/\/doi.org\/10.1158\/0008-5472.can-04-0083.","journal-title":"Cancer Res"},{"key":"2615_CR7","doi-asserted-by":"publisher","first-page":"10152","DOI":"10.1073\/pnas.0702916104","volume":"104","author":"ED Kirson","year":"2007","unstructured":"Kirson ED, Dbaly V, Tovarys F, Vymazal J, Soustiel JF, Itzhaki A, et al. Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. Proc Natl Acad Sci USA. 2007;104:10152\u20137. https:\/\/doi.org\/10.1073\/pnas.0702916104.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2615_CR8","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1053\/j.seminoncol.2014.09.006","volume":"41","author":"M Giladi","year":"2014","unstructured":"Giladi M, Weinberg U, Schneiderman RS, Porat Y, Munster M, Voloshin T, et al. Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo. Semin Oncol. 2014;41:S35\u201341. https:\/\/doi.org\/10.1053\/j.seminoncol.2014.09.006.","journal-title":"Semin Oncol"},{"key":"2615_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pan.2013.11.009","volume":"14","author":"M Giladi","year":"2014","unstructured":"Giladi M, Schneiderman RS, Porat Y, Munster M, Itzhaki A, Mordechovich D, et al. Mitotic disruption and reduced clonogenicity of pancreatic cancer cells in vitro and in vivo by tumor treating fields. Pancreatology. 2014;14:54\u201363. https:\/\/doi.org\/10.1016\/j.pan.2013.11.009.","journal-title":"Pancreatology"},{"key":"2615_CR10","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1002\/ijc.30406","volume":"139","author":"T Voloshin","year":"2016","unstructured":"Voloshin T, Munster M, Blatt R, Shteingauz A, Roberts PC, Schmelz EM, et al. Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo. Int J Cancer. 2016;139:2850\u20138. https:\/\/doi.org\/10.1002\/ijc.30406.","journal-title":"Int J Cancer"},{"key":"2615_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.lungcan.2021.08.011","volume":"160","author":"H Mumblat","year":"2021","unstructured":"Mumblat H, Martinez-Conde A, Braten O, Munster M, Dor-On E, Schneiderman RS, et al. Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models. Lung Cancer. 2021;160:99\u2013110. https:\/\/doi.org\/10.1016\/j.lungcan.2021.08.011.","journal-title":"Lung Cancer"},{"key":"2615_CR12","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.ijrobp.2019.04.008","volume":"104","author":"MT Ballo","year":"2019","unstructured":"Ballo MT, Urman N, Lavy-Shahaf G, Grewal J, Bomzon Z, Toms S. Correlation of tumor treating fields dosimetry to survival outcomes in newly diagnosed glioblastoma: a large-scale numerical simulation-based analysis of data from the Phase 3 EF-14 randomized trial. Int J Radiat Oncol Biol Phys. 2019;104:1106\u201313. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.04.008.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2615_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-023-04348-w","volume":"164","author":"MT Ballo","year":"2023","unstructured":"Ballo MT, Conlon P, Lavy-Shahaf G, Kinzel A, Vymazal J, Rulseh AM. Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis. J Neurooncol. 2023;164:1\u20139. https:\/\/doi.org\/10.1007\/s11060-023-04348-w.","journal-title":"J Neurooncol"},{"key":"2615_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep18046","volume":"5","author":"M Giladi","year":"2015","unstructured":"Giladi M, Schneiderman RS, Voloshin T, Porat Y, Munster M, Blat R, et al. Mitotic spindle disruption by alternating electric fields leads to improper chromosome segregation and mitotic catastrophe in cancer cells. Sci Rep. 2015;5:18046. https:\/\/doi.org\/10.1038\/srep18046.","journal-title":"Sci Rep"},{"key":"2615_CR15","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.3390\/cancers14122959","volume":"14","author":"S Davidi","year":"2022","unstructured":"Davidi S, Jacobovitch S, Shteingauz A, Martinez-Conde A, Braten O, Tempel-Brami C, et al. Tumor Treating Fields (TTFields) concomitant with sorafenib inhibit hepatocellular carcinoma in vitro and in vivo. Cancers. 2022;14:2959. https:\/\/doi.org\/10.3390\/cancers14122959.","journal-title":"Cancers"},{"key":"2615_CR16","doi-asserted-by":"publisher","unstructured":"Haber A, Shapira N, Zeidan A, Giladi M, Story MD. Implications of electrical properties of cells for treatment specificity of electric\/electromagnetic fields-based therapeutic approaches: Comment on \u201cThe distinguishing electric properties of cancer cells\u201d by E. Di Gregorio et al. Phys Life Rev. 2023. https:\/\/doi.org\/10.1016\/j.plrev.2023.09.019.","DOI":"10.1016\/j.plrev.2023.09.019"},{"key":"2615_CR17","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.3390\/ijms19113684","volume":"19","author":"Y Jo","year":"2018","unstructured":"Jo Y, Kim EH, Sai S, Kim JS, Cho JM, Kim H, et al. Functional biological activity of sorafenib as a tumor-treating field sensitizer for glioblastoma therapy. Int J Mol Sci. 2018;19:3684. https:\/\/doi.org\/10.3390\/ijms19113684.","journal-title":"Int J Mol Sci"},{"key":"2615_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.136","volume":"8","author":"NK Karanam","year":"2017","unstructured":"Karanam NK, Srinivasan K, Ding L, Sishc B, Saha D, Story MD. Tumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell lines. Cell Death Dis. 2017;8:e2711. https:\/\/doi.org\/10.1038\/cddis.2017.136.","journal-title":"Cell Death Dis"},{"key":"2615_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1085-9","volume":"9","author":"A Shteingauz","year":"2018","unstructured":"Shteingauz A, Porat Y, Voloshin T, Schneiderman RS, Munster M, Zeevi E, et al. AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields). Cell Death Dis. 2018;9:1074. https:\/\/doi.org\/10.1038\/s41419-018-1085-9.","journal-title":"Cell Death Dis"},{"key":"2615_CR20","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00262-020-02534-7","volume":"69","author":"T Voloshin","year":"2020","unstructured":"Voloshin T, Kaynan N, Davidi S, Porat Y, Shteingauz A, Schneiderman RS, et al. Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy. Cancer Immunol Immunother. 2020;69:1191\u2013204. https:\/\/doi.org\/10.1007\/s00262-020-02534-7.","journal-title":"Cancer Immunol Immunother"},{"key":"2615_CR21","doi-asserted-by":"publisher","unstructured":"Chen D, Le SB, Hutchinson TE, Calinescu AA, Sebastian M, Jin D, et al. Tumor treating fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma. J Clin Invest. 2022;132. https:\/\/doi.org\/10.1172\/JCI149258.","DOI":"10.1172\/JCI149258"},{"key":"2615_CR22","doi-asserted-by":"publisher","first-page":"14073","DOI":"10.3390\/ijms232214073","volume":"23","author":"Y Barsheshet","year":"2022","unstructured":"Barsheshet Y, Voloshin T, Brant B, Cohen G, Koren L, Blatt R, et al. Tumor Treating Fields (TTFields) concomitant with immune checkpoint inhibitors are therapeutically effective in non-small cell lung cancer (NSCLC) in vivo model. Int J Mol Sci. 2022;23:14073. https:\/\/doi.org\/10.3390\/ijms232214073.","journal-title":"Int J Mol Sci"},{"key":"2615_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-017-0941-6","volume":"12","author":"M Giladi","year":"2017","unstructured":"Giladi M, Munster M, Schneiderman RS, Voloshin T, Porat Y, Blat R, et al. Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells. Radiat Oncol. 2017;12:206. https:\/\/doi.org\/10.1186\/s13014-017-0941-6.","journal-title":"Radiat Oncol"},{"key":"2615_CR24","doi-asserted-by":"publisher","first-page":"62267","DOI":"10.18632\/oncotarget.11407","volume":"7","author":"EH Kim","year":"2016","unstructured":"Kim EH, Kim YH, Song HS, Jeong YK, Lee JY, Sung J, et al. Biological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiation. Oncotarget. 2016;7:62267\u201379. https:\/\/doi.org\/10.18632\/oncotarget.11407.","journal-title":"Oncotarget"},{"key":"2615_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11060-023-04308-4","volume":"163","author":"H Fishman","year":"2023","unstructured":"Fishman H, Monin R, Dor-On E, Kinzel A, Haber A, Giladi M, et al. Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines. J Neuro-Oncol. 2023;163:83\u201394. https:\/\/doi.org\/10.1007\/s11060-023-04308-4.","journal-title":"J Neuro-Oncol"},{"key":"2615_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1402851","volume":"14","author":"Y Berckmans","year":"2024","unstructured":"Berckmans Y, Ene HM, Ben-Meir K, Martinez-Conde A, Wouters R, Van den Ende B, et al. Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance. Front Oncol. 2024;14:1402851. https:\/\/doi.org\/10.3389\/fonc.2024.1402851.","journal-title":"Front Oncol"},{"key":"2615_CR27","doi-asserted-by":"publisher","unstructured":"Branter J, Estevez-Cebrero M, Diksin M, Griffin M, Castellanos-Uribe M, May S, et al. Genome-wide expression and anti-proliferative effects of electric field therapy on pediatric and adult brain tumors. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms23041982.","DOI":"10.3390\/ijms23041982"},{"key":"2615_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68473-6","volume":"10","author":"Y-J Lee","year":"2020","unstructured":"Lee Y-J, Seo HW, Baek J-H, Lim SH, Hwang S-G, Kim EH. Gene expression profiling of glioblastoma cell lines depending on TP53 status after tumor-treating fields (TTFields) treatment. Sci Rep. 2020;10:12272. https:\/\/doi.org\/10.1038\/s41598-020-68473-6.","journal-title":"Sci Rep"},{"key":"2615_CR29","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41419-022-05127-7","volume":"13","author":"S Xu","year":"2022","unstructured":"Xu S, Luo C, Chen D, Tang L, Chen L, Liu Z. Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma. Cell Death Dis. 2022;13:721. https:\/\/doi.org\/10.1038\/s41419-022-05127-7.","journal-title":"Cell Death Dis"},{"key":"2615_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05073-4","volume":"13","author":"L Mannarino","year":"2022","unstructured":"Mannarino L, Mirimao F, Panini N, Paracchini L, Marchini S, Beltrame L, et al. Tumor treating fields affect mesothelioma cell proliferation by exerting histotype-dependent cell cycle checkpoint activations and transcriptional modulations. Cell Death Dis. 2022;13:612. https:\/\/doi.org\/10.1038\/s41419-022-05073-4.","journal-title":"Cell Death Dis"},{"key":"2615_CR31","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1158\/1538-7445.Am2023-2723","volume":"83","author":"N Flint-Brodsly","year":"2023","unstructured":"Flint-Brodsly N, Zeevi E, Wainer-Katsir K, Fishman H, Martinez-Conde A, Dor-On E, et al. Abstract 2723: Treatment of gastric cancer cells with tumor treating fields (TTFields) and concomitant FOLFOX. Cancer Res. 2023;83:2723. https:\/\/doi.org\/10.1158\/1538-7445.Am2023-2723.","journal-title":"Cancer Res"},{"key":"2615_CR32","doi-asserted-by":"publisher","unstructured":"Yoshimoto K, Mizoguchi M, Hata N, Murata H, Hatae R, Amano T, et al. Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma. Front Oncol. 2012;2. https:\/\/doi.org\/10.3389\/fonc.2012.00186.","DOI":"10.3389\/fonc.2012.00186"},{"key":"2615_CR33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.20892\/j.issn.2095-3941.2017.0033","volume":"14","author":"J Bai","year":"2017","unstructured":"Bai J, Li Y, Zhang G. Cell cycle regulation and anticancer drug discovery. Cancer Biol Med. 2017;14:348\u201362. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2017.0033.","journal-title":"Cancer Biol Med"},{"key":"2615_CR34","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41416-023-02454-0","volume":"129","author":"A Vanderlinden","year":"2023","unstructured":"Vanderlinden A, Jones CG, Myers KN, Rominiyi O, Collis SJ. DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells. Br J Cancer. 2023;129:1829\u201340. https:\/\/doi.org\/10.1038\/s41416-023-02454-0.","journal-title":"Br J Cancer"},{"key":"2615_CR35","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1093\/hmg\/ddr306","volume":"20","author":"M Palmieri","year":"2011","unstructured":"Palmieri M, Impey S, Kang H, di Ronza A, Pelz C, Sardiello M, et al. Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Human Mol Genet. 2011;20:3852\u201366. https:\/\/doi.org\/10.1093\/hmg\/ddr306.","journal-title":"Human Mol Genet"},{"key":"2615_CR36","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1038\/s12276-023-01079-w","volume":"55","author":"M Xiao","year":"2023","unstructured":"Xiao M, Xu J, Wang W, Zhang B, Liu J, Li J, et al. Functional significance of cholesterol metabolism in cancer: from threat to treatment. Exp Mol Med. 2023;55:1982\u201395. https:\/\/doi.org\/10.1038\/s12276-023-01079-w.","journal-title":"Exp Mol Med"},{"key":"2615_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1274335","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang Z, Wang Y, Li Z, Xue W, Hu S, Kong X. Lipid metabolism as a target for cancer drug resistance: progress and prospects. Front Pharm. 2023;14:1274335. https:\/\/doi.org\/10.3389\/fphar.2023.1274335.","journal-title":"Front Pharm"},{"key":"2615_CR38","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41419-025-07546-8","volume":"16","author":"A Klein-Goldberg","year":"2025","unstructured":"Klein-Goldberg A, Voloshin T, Zemer Tov E, Paz R, Somri-Gannam L, Volodin A, et al. Role of the PI3K\/AKT signaling pathway in the cellular response to Tumor Treating Fields (TTFields). Cell Death Dis. 2025;16:210. https:\/\/doi.org\/10.1038\/s41419-025-07546-8.","journal-title":"Cell Death Dis"},{"key":"2615_CR39","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S1470-2045(23)00344-3","volume":"24","author":"T Leal","year":"2023","unstructured":"Leal T, Kotecha R, Ramlau R, Zhang L, Milanowski J, Cobo M, et al. Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study. Lancet Oncol. 2023;24:1002\u201317. https:\/\/doi.org\/10.1016\/S1470-2045(23)00344-3.","journal-title":"Lancet Oncol"},{"key":"2615_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112278","volume":"144","author":"AC Nickel","year":"2021","unstructured":"Nickel AC, Picard D, Qin N, Wolter M, Kaulich K, Hewera M, et al. Longitudinal stability of molecular alterations and drug response profiles in tumor spheroid cell lines enables reproducible analyses. Biomed Pharmacother. 2021;144:112278. https:\/\/doi.org\/10.1016\/j.biopha.2021.112278.","journal-title":"Biomed Pharmacother"},{"key":"2615_CR41","doi-asserted-by":"publisher","first-page":"D923","DOI":"10.1093\/nar\/gky872","volume":"47","author":"D van der Meer","year":"2019","unstructured":"van der Meer D, Barthorpe S, Yang W, Lightfoot H, Hall C, Gilbert J, et al. Cell Model Passports-a hub for clinical, genetic and functional datasets of preclinical cancer models. Nucleic Acids Res. 2019;47:D923\u2013d929. https:\/\/doi.org\/10.1093\/nar\/gky872.","journal-title":"Nucleic Acids Res"},{"key":"2615_CR42","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","volume":"170","author":"A Tsherniak","year":"2017","unstructured":"Tsherniak A, Vazquez F, Montgomery PG, Weir BA, Kryukov G, Cowley GS, et al. Defining a cancer dependency map. Cell. 2017;170:564\u2013576.e516. https:\/\/doi.org\/10.1016\/j.cell.2017.06.010.","journal-title":"Cell"},{"key":"2615_CR43","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. 2022. https:\/\/www.R-project.org\/."},{"key":"2615_CR44","unstructured":"RStudio Team. RStudio: Integrated Development for R. RStudio, PBC, Boston, MA. 2020. http:\/\/www.rstudio.com\/."},{"key":"2615_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-023-01586-x","volume":"11","author":"M-A Da-Veiga","year":"2023","unstructured":"Da-Veiga M-A, Coppieters N, Lombard A, Rogister B, Neirinckx V, Piette C. Comprehensive profiling of stem-like features in pediatric glioma cell cultures and their relation to the subventricular zone. Acta Neuropathol Commun. 2023;11:96. https:\/\/doi.org\/10.1186\/s40478-023-01586-x.","journal-title":"Acta Neuropathol Commun"},{"key":"2615_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/2472630318803749","volume":"24","author":"KM Wilson","year":"2019","unstructured":"Wilson KM, Mathews-Griner LA, Williamson T, Guha R, Chen L, Shinn P, et al. Mutation profiles in glioblastoma 3D oncospheres modulate drug efficacy. SLAS Technol. 2019;24:28\u201340. https:\/\/doi.org\/10.1177\/2472630318803749.","journal-title":"SLAS Technol"},{"key":"2615_CR47","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32:2847\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btw313.","journal-title":"Bioinformatics"},{"key":"2615_CR48","doi-asserted-by":"publisher","unstructured":"Rio DC, Ares M, Hannon GJ, Nilsen TW. Purification of RNA using TRIzol (TRI Reagent). Cold Spring Harbor Protoc. 2010;2010:pdb.prot5439. https:\/\/doi.org\/10.1101\/pdb.prot5439","DOI":"10.1101\/pdb.prot5439"},{"key":"2615_CR49","unstructured":"Andrews S. FASTQC. A quality control tool for high throughput sequence data. 2010. https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/."},{"key":"2615_CR50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635.","journal-title":"Bioinformatics"},{"key":"2615_CR51","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels P, Magnusson M, Lundin S, Kaller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 2016;32:3047\u20138. https:\/\/doi.org\/10.1093\/bioinformatics\/btw354.","journal-title":"Bioinformatics"},{"key":"2615_CR52","doi-asserted-by":"publisher","unstructured":"Danecek P, Bonfield JK, Liddle J, Marshall J, Ohan V, Pollard MO, et al. Twelve years of SAMtools and BCFtools. Gigascience. 2021;10. https:\/\/doi.org\/10.1093\/gigascience\/giab008.","DOI":"10.1093\/gigascience\/giab008"},{"key":"2615_CR53","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139\u201340. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616.","journal-title":"Bioinformatics"},{"key":"2615_CR54","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gr.209601.116","volume":"27","author":"T Smith","year":"2017","unstructured":"Smith T, Heger A, Sudbery I. UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy. Genome Res. 2017;27:491\u20139. https:\/\/doi.org\/10.1101\/gr.209601.116.","journal-title":"Genome Res"},{"key":"2615_CR55","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1093\/bioinformatics\/btac166","volume":"38","author":"GH Putri","year":"2022","unstructured":"Putri GH, Anders S, Pyl PT, Pimanda JE, Zanini F, Boeva V. Analysing high-throughput sequencing data in Python with HTSeq 2.0. Bioinformatics. 2022;38:2943\u20135. https:\/\/doi.org\/10.1093\/bioinformatics\/btac166.","journal-title":"Bioinformatics"},{"key":"2615_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/nargab\/lqaa078","volume":"2","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Parmigiani G, Johnson WE. ComBat-seq: batch effect adjustment for RNA-seq count data. NAR Genomics Bioinform. 2020;2:lqaa078. https:\/\/doi.org\/10.1093\/nargab\/lqaa078.","journal-title":"NAR Genomics Bioinform"},{"key":"2615_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law CW, Chen Y, Shi W, Smyth GK. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15:R29. https:\/\/doi.org\/10.1186\/gb-2014-15-2-r29.","journal-title":"Genome Biol"},{"key":"2615_CR58","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/bioinformatics\/btn647","volume":"25","author":"A Kauffmann","year":"2009","unstructured":"Kauffmann A, Gentleman R, Huber W. arrayQualityMetrics-a bioconductor package for quality assessment of microarray data. Bioinformatics. 2009;25:415\u20136. https:\/\/doi.org\/10.1093\/bioinformatics\/btn647.","journal-title":"Bioinformatics"},{"key":"2615_CR59","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","journal-title":"Nucleic Acids Res"},{"key":"2615_CR60","unstructured":"Kolde R, pheatmap: Pretty Heatmaps. R package version 1.0.12. 2019. https:\/\/CRAN.R-project.org\/package=pheatmap."},{"key":"2615_CR61","doi-asserted-by":"crossref","unstructured":"Wickham H. ggplot2: elegant graphics for data analysis. New York: Springer-Verlag; 2016.","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"2615_CR62","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/bioinformatics\/btx657","volume":"34","author":"T Galili","year":"2018","unstructured":"Galili T, O\u2019Callaghan A, Sidi J, Sievert C. heatmaply: an R package for creating interactive cluster heatmaps for online publishing. Bioinformatics. 2018;34:1600\u20132. https:\/\/doi.org\/10.1093\/bioinformatics\/btx657.","journal-title":"Bioinformatics"},{"key":"2615_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v025.i03","volume":"25","author":"M Hahsler","year":"2008","unstructured":"Hahsler M, Hornik K, Buchta C. Getting things in order: an introduction to the R package seriation. J Stat Softw. 2008;25:1\u201334. https:\/\/doi.org\/10.18637\/jss.v025.i03.","journal-title":"J Stat Softw"},{"key":"2615_CR64","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1093\/bioinformatics\/btv428","volume":"31","author":"T Galili","year":"2015","unstructured":"Galili T. dendextend: an R package for visualizing, adjusting and comparing trees of hierarchical clustering. Bioinformatics. 2015;31:3718\u201320. https:\/\/doi.org\/10.1093\/bioinformatics\/btv428.","journal-title":"Bioinformatics"},{"key":"2615_CR65","unstructured":"Wickham H, Fran\u00e7ois R, Henry L, M\u00fcller K, Vaughan D. dplyr: A Grammar of Data Manipulation. 2023. https:\/\/dplyr.tidyverse.org, https:\/\/github.com\/tidyverse\/dplyr."},{"key":"2615_CR66","doi-asserted-by":"publisher","unstructured":"Wickham H, Averick M, Bryan J, Chang W, McGowan LDA, Fran\u00e7ois R, et al. Welcome to the Tidyverse. J Open Source Softw. 2019;4:1686. https:\/\/doi.org\/10.21105\/joss.01686.","DOI":"10.21105\/joss.01686"},{"key":"2615_CR67","unstructured":"Wickham H, Vaughan D, Girlich M. tidyr: Tidy Messy Data. 2023. https:\/\/tidyr.tidyverse.org, https:\/\/github.com\/tidyverse\/tidyr."},{"key":"2615_CR68","unstructured":"Wickham H. stringr: Simple, Consistent Wrappers for Common String Operations. 2022. https:\/\/stringr.tidyverse.org, https:\/\/github.com\/tidyverse\/stringr."},{"key":"2615_CR69","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49:D605\u2013d612. https:\/\/doi.org\/10.1093\/nar\/gkaa1074.","journal-title":"Nucleic Acids Res"},{"key":"2615_CR70","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2615_CR71","doi-asserted-by":"publisher","first-page":"D498","DOI":"10.1093\/nar\/gkz1031","volume":"48","author":"B Jassal","year":"2020","unstructured":"Jassal B, Matthews L, Viteri G, Gong C, Lorente P, Fabregat A, et al. The reactome pathway knowledgebase. Nucleic Acids Res. 2020;48:D498\u2013D503. https:\/\/doi.org\/10.1093\/nar\/gkz1031.","journal-title":"Nucleic Acids Res"},{"key":"2615_CR72","unstructured":"Wei T, Simko V. R package 'corrplot': Visualization of a Correlation Matrix. (Version 0.92). 2021. https:\/\/github.com\/taiyun\/corrplot."},{"key":"2615_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13983-9","volume":"11","author":"M Paczkowska","year":"2020","unstructured":"Paczkowska M, Barenboim J, Sintupisut N, Fox NS, Zhu H, Abd-Rabbo D, et al. Integrative pathway enrichment analysis of multivariate omics data. Nat Commun. 2020;11:735. https:\/\/doi.org\/10.1038\/s41467-019-13983-9.","journal-title":"Nat Commun"},{"key":"2615_CR74","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504. https:\/\/doi.org\/10.1101\/gr.1239303.","journal-title":"Genome Res"},{"key":"2615_CR75","doi-asserted-by":"publisher","first-page":"e13984","DOI":"10.1371\/journal.pone.0013984","volume":"5","author":"D Merico","year":"2010","unstructured":"Merico D, Isserlin R, Stueker O, Emili A, Bader GD. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS ONE. 2010;5:e13984. https:\/\/doi.org\/10.1371\/journal.pone.0013984.","journal-title":"PLoS ONE"},{"key":"2615_CR76","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.12688\/f1000research.9090.1","volume":"5","author":"M Kucera","year":"2016","unstructured":"Kucera M, Isserlin R, Arkhangorodsky A, Bader GD. AutoAnnotate: a cytoscape app for summarizing networks with semantic annotations. F1000Res. 2016;5:1717. https:\/\/doi.org\/10.12688\/f1000research.9090.1.","journal-title":"F1000Res"},{"key":"2615_CR77","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer A, Green J, Pollard J Jr, Tugendreich S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics. 2014;30:523\u201330. https:\/\/doi.org\/10.1093\/bioinformatics\/btt703.","journal-title":"Bioinformatics"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02615-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02615-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02615-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:55:23Z","timestamp":1752137723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02615-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2615"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02615-5","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KWK, AH, HF, GLS, HE, RFG, ZD, AMC, ED, YPo, MG, and UW are employees of Novocure and hold stocks at Novocure Ltd. YPa holds stocks in Novocure Ltd. MG, UW and YPa hold several patents related to TTFields. All other authors declare they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"319"}}